C5aR2

Background

In the process of complement activation, complement C5 is cleaved by C5 convertases into C5b to form the membrane attack complex (MAC), releasing an anaphylatoxin product C5a. C5a is a potent chemotactic agent and an anaphylatoxin mediating multiple inflammatory reactions by binding to C5a receptors. There are two C5a receptors, C5aR1 (CD88) and C5aR2.

C5a anaphylatoxin chemotactic receptor 2 (C5aR2), also known as C5L2 and GPR77, is a G-protein coupled receptor (GPCR) composed of a single polypeptide chain. The total 337 amino acid residues fold into seven-transmembrane α-helices and an extracellular N-terminus. Similar to C5aR1, at the N-terminus Asn3 of C5aR2 lies a single N-linked glycosylation site, which is of great significance for the ligand binding and functioning. Different from C5aR1, the intracellular C-terminus of C5aR2 contains several serine residues and phosphorylation sites for signaling and desensitization. And C5aR2 has a different DRY motif and lacks NPXXY intracellular motifs, both of which are necessary for G-protein coupling and signal transduction for GPCRs.

C5aR2 is an enigmatic receptor functioning by binding to its ligands complement C5a and C5a des-arginine, although the exact action in immune response has been controversial.

1. Serve as a modulator of C5aR1 signaling: C5aR2 may compete with C5aR1 for binding to C5a and C5a-desArg, thereby reducing the concentrations of C5a and C5a-desArg and C5aR1 signaling.
2. Modulatory activities on other receptors: C5aR2 also has been demonstrated to mediate inflammatory reactions through affecting some innate immune receptors, such as Toll-like receptors, and NLRP3 inflammasome system.
3. Functions in adaptive immunity: C5aR2 has a potential role in inducing the generation and development of Treg cells while inhibiting the development and differentiation of Th17 and Th1 cells.

Fig. 1 Structure of C5aR. Distributed under CC BY 3.0, from Wiki, without modification.

C5AR2 Functional Service

Creative Biolabs offers a comprehensive array of C5AR2-targeted products, including anti-C5AR2 antibodies and aptamers, C5AR2 detection ELISA kits, recombinant C5AR2 proteins, and complement C5L2 peptides. These precisely engineered resources are indispensable for advancing research efforts aimed at devising therapeutic strategies for a broad spectrum of diseases.

Fig.2 Cell-specific C5AR2 knockout mouse line: C5AR2 expression analysis.¹

The function of C5aR2, the second receptor for the complement component C5a, remains inadequately elucidated within immunology. Researchers previously identified its critical involvement in neutrophil-mediated autoimmune disease, epidermolysis bullosa acquisita (EBA), using globally C5aR2-deficient mice. Hypothesizing that the effects were neutrophil-specific, researchers developed a LysM-specific C5aR2 knockout mouse line. Successful C5aR2 deletion, confirmed at genetic and protein levels, did not affect C5aR1 expression. In EBA models, LysM-specific C5aR2 deficiency lessened disease severity, with neutrophils showing reduced activation post-C5a stimulation and elevated FcgRIIb expression. These findings highlight C5aR2’s role in modulating neutrophil response, impacting immune complex interactions crucial to autoimmune pathogenesis.

Creative Biolabs offers a bespoke array of C5AR2-centered services, incorporating comprehensive interaction assessments and additional functional solutions. These meticulously designed offerings aim to assist our distinguished clients in their scientific investigations and clinical applications.

Reference

1. Seiler, Daniel L., et al. "The complement receptor C5aR2 regulates neutrophil activation and function contributing to neutrophil-driven epidermolysis bullosa acquisita." Frontiers in Immunology 14 (2023): 1197709. Distributed under Open Access license CC BY 4.0, without modification.